AzTrials
AzTrials

Hearing Loss, BilateralNCT03674086

Evaluation of the eAdjust Application

An observational study of Hearing Loss, Bilateral and Hearing Loss, Sensorineural, run by Nottingham University Hospitals NHS Trust at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Despite being effective, the majority of people who would benefit from using hearing aids do not access them. For those who do obtain hearing aids, around 20% do not wear them regularly. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
eAdjust 0.2 hearing aid smartphone application (or app)
Type of treatment
Medical device
How many people
46 participants
Where
1 siteUnited Kingdom
Study dates
23 Aug 2018to 30 Apr 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Hearing aid users (first-time and existing) will be recruited from Nottingham Audiology Adult Service, Nottingham University Hospitals NHS Trust (secondary care). Immediately following the patient's hearing assessment appointment, a member of the patient's usual care team (audiologist) will identify eligible patients.

Who may be able to join

  • Adults aged ≥18 years.
  • With hearing loss type: symmetric (not more than 20 dB difference) and sensorineural.
  • With mild to severe hearing loss in the categories: N2, N3, N4, N5, S2 and S3.
  • No disturbing tinnitus.
  • No contraindications against wearing hearing aids (e.g. ear disease or motor impairment).
  • Hearing aid user:
Show all 11Show fewer
  • First-time (using hearing aids < 3 months)
  • Existing (using hearing aids > 6 months)
  • Owns an iPhone (v5 and IOS 10 or higher) and uses functions of her/his smartphone which exceed calling and writing text messages.
  • Willing to wear test hearing aids, to use the eAdjust App, to take notes about experiences and to perform various tasks during the study period.
  • English as a first spoken language or a good understanding of English. It is important that participants can understand the content of the resources and work with the interactive elements, as well as be able to answer outcome questionnaires, to ensure valid data are collected.

Who cannot join

  • Unable to complete the questionnaires without assistance due to age-related problems (e.g. cognitive decline or dementia), to ensure valid data are collected.

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • National Institute for Health Research Nottingham Biomedical Research Centre

    Nottingham, Non-US/Non-Canadian, NG1 5DU

Other trials in United Kingdom

About this study

Official title: Evaluation of the eAdjust Application to Provide Benefits in Users of Smartphone-connected Hearing Aids

Despite being effective, the majority of people who would benefit from using hearing aids do not access them. For those who do obtain hearing aids, around 20% do not wear them regularly. People often do not use their hearing aids because they continue to experience difficulties when listening to and understanding speech in noisy situations.

Conventional hearing aids must be programmed and adjusted by a trained audiologist with specialist equipment and therefore provide limited user-control over the hearing aid's functionality. In comparison to conventional hearing aids, Smartphone-connected hearing aids enable patients to adjust their programmes themselves in different situations using a Smartphone application. Smartphone-connectivity can supplement clinical practices, as patients can adjust their hearing aids without the need to visit the clinic. This has the potential to empower patients to be actively involved in their own hearing healthcare.

Read more

A systematic review assessing the effectiveness of alternative listening devices showed that there is no published high-quality research assessing the clinical effectiveness of Smartphone-connected hearing aids. Furthermore, a usability research study has shown that patients want to personalise and adjust their own HA programmes to meet their individual needs. Having carried out the early development work, the next step would be to carry out a study to evaluate smartphone-connected hearing aids, in accordance with the MRC guidelines on developing and evaluating complex interventions.

This study will assess the benefits of a smartphone application, eAdjust that has been developed for use with Phonak Audeo B90-Direct hearing aids. The eAdjust app connects to the hearing aid via Bluetooth, and enables hearing aid users to fine-tune their hearing aids via their smartphone. The benefits of the eAdjust app will be assessed in the real-world as well as in the laboratory. A mixed methods approach will be taken, using both behavioural and patient reported outcomes.

Being tested
eAdjust 0.2 hearing aid smartphone application (or app)
Medical subject headings
Hearing Loss, Bilateral, Hearing Loss, Sensorineural

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • eAdjust 0.2 hearing aid smartphone application (or app)Device

    The app connects to the Audeo B-90 Direct hearing aids via Bluetooth. The intended use for the app to enable hearing aid users to fine-tune their hearing aids. The app contains a series of sound modifiers, factory presets, sound modifier presets.

Study groups in NCT03674086
Study groupRoleWhat they receive
First-time hearing aid userUsing hearing aids less than or equal to three months.
Receives: Device: eAdjust 0.2 hearing aid smartphone application (or app)
Existing hearing aid userUsing hearing aids for 6 months or more.
Receives: Device: eAdjust 0.2 hearing aid smartphone application (or app)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Hearing Handicap Inventory for the Elderly

    25-item self-reported questionnaire assessing the effects of hearing loss on the emotional and social/situational adjustment. Scored using a three-point scale.

    Measured: Change from Baseline following 7-weeks of intervention use.

Secondary outcomes (12)
  1. Glasgow Hearing Aid Benefit Profile

    Assesses self-reported hearing disability and handicap (Part I), as well as hearing aid use, benefit, residual disability and satisfaction (Part II). Each domain is measured on a five-point scale.

    Measured: Baseline (Part I) and following 7-weeks of intervention use (Part II).

  2. Vanderbilt Fatigue Scale for Adults with Hearing Loss

    A 40-item self-report measure of listening effort and fatigue. Scored using a five-point scale.

    Measured: Change from Baseline following 7-weeks of intervention use.

  3. Device-Orientated Subjective Outcome scale

    Self-report questionnaire suitable for quantifying subjective hearing aid outcomes. Scored using a seven-point response scale.

    Measured: Change from Baseline following 7-weeks of intervention use.

  4. Glasgow Hearing Aid Difference Profile (existing hearing aid users only)

    Assesses self-reported use and residual disability with 'old' hearing aids (Part I), as well as use and residual disability with 'new' hearing aids, and the difference in benefit and and satisfaction between 'old and 'new' hearing aids (Part II). Each domain is measured on a five-point scale.

    Measured: Change from Baseline following 7-weeks of intervention use.

  5. Auditory Lifestyle and Demands Questionnaire

    Self-report measure of auditory lifestyle.

    Measured: Following 1-week of intervention use.

  6. Clarity and Comfort Questionnaire

    Self-report measure of hearing aid preferences concerning sound clarity and comfort.

    Measured: Following 1-week of intervention use.

  7. Hearing aid datalogging

    Hearing aid use in hours, internal to the hearing aid.

    Measured: Following 1-week and 7-weeks of intervention use.

  8. Montreal Cognitive Assessment

    Validated screening tool for mild cognitive impairment.

    Measured: Following 1-week of intervention use.

  9. BKB Speeh-In-Noise Test

    Behavioural measure of speech intelligibility in the presence of background noise.

    Measured: Following 1-week and 7-weeks of intervention use.

  10. eAdjust 0.2 app datalogging

    Usage data, internal to the app.

    Measured: Following 2-week and 6-weeks of intervention use.

  11. App real-world use questionnaire

    Self-report questionnaire of app usage. Consists of closed- and open-ended questions.

    Measured: Following 2-week and 6-weeks of intervention use.

  12. Hearing aid tasks

    Self-report questionnaire of app functionality in different environments.

    Measured: Following 2-week and 6-weeks of intervention use.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Sep 2018
  2. Study start23 Aug 2018
  3. Primary completion14 Dec 2018
  4. Study completion30 Apr 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
46 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03674086
Sponsor's protocol ID
18IH002
Status last verified
Mar 2019
First submitted
13 Sep 2018
Last updated
19 Feb 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Gomez R, Habib A, Maidment DW, Ferguson MA. Smartphone-Connected Hearing Aids Enable and Empower Self-Management of Hearing Loss: A Qualitative Interview Study Underpinned by the Behavior Change Wheel. Ear Hear. 2022 May/Jun;43(3):921-932. doi: 10.1097/AUD.0000000000001143.

    PubMed 34653030

Questions about this trial

What is this clinical trial studying?

An observational study of Hearing Loss, Bilateral and Hearing Loss, Sensorineural, run by Nottingham University Hospitals NHS Trust at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Feb 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Hearing Handicap Inventory for the Elderly (time frame: Change from Baseline following 7-weeks of intervention use.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03674086, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Feb 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Evaluation of the eAdjust Application (NCT03674086) | AzTrials